Former FDA Deputy weighs in on the push into ‘real-time clinical trials’
There’s reason to be excited - even if it seems incremental
Making sense of healthcare deals, technology, policy, and the occasional industry curveball.
There’s reason to be excited - even if it seems incremental
It's called SOS.
Ruth here. On Monday, I sat down with the CEO of a health tech company and two health system executives
This is the model proven by Grow Therapy, now valued at $3B
This is the second part of Sam Toole's series on the future of the EHR
This is the second part of Sam Toole's series on the future of the EHR
Startups have for years complained about the difficulty of working with Epic, the electronic health record company with the largest
Second Opinion partnered with Confido to determine which companies should make the cut.
There's a lot more of them than we expected!